Literature DB >> 25998603

2014 consensus statement on improving pelvic floor muscle training adherence: International Continence Society 2011 State-of-the-Science Seminar.

Chantale Dumoulin1,2, Jean Hay-Smith3,4, Helena Frawley5,6, Doreen McClurg7, Dianne Alewijnse8, Kari Bo9, Kathryn Burgio10,11, Shu-Yueh Chen12, Pauline Chiarelli13, Sarah Dean14, Suzanne Hagen15, Julia Herbert16, Aishath Mahfooza17, Frances Mair18, Diane Stark19, Marijke Van Kampen20.   

Abstract

AIMS: To summarize the findings and "expert-panel" consensus of the State-of-the-Science Seminar on pelvic floor muscle training (PFMT) adherence held prior to the 41st International Continence Society scientific meeting, Glasgow, 2011.
METHODS: Summaries of research and theory about PFMT adherence (based on a comprehensive literature search) were presented by subject experts at the 2011 Seminar to generate discussion and guidance for clinical practice and future research. Supplemental research, post-seminar, resulted in, three review papers summarizing: (1) relevant behavioral theories, (2) adherence measurement, determinants and effectiveness of PFMT adherence interventions, and (3) patients' PFMT experiences. A fourth, reported findings from an online survey of health professionals and the public.
RESULTS: Few high-quality studies were found. Paper I summarizes 12 behavioral frameworks relevant to theoretical development of PFMT adherence interventions and strategies. Findings in Paper II suggest both PFMT self-efficacy and intention-to-adhere predict PFMT adherence. Paper III identified six potential adherence modifiers worthy of further investigation. Paper IV found patient-related factors were the biggest adherence barrier to PFMT adherence.
CONCLUSION: Given the lack of high-quality studies, the conclusions were informed by expert opinion. Adherence is central to short- and longer-term PFMT effect. More attention and explicit reporting is needed regarding: (1) applying health behavior theory in PFMT program planning; (2) identifying adherence determinants; (3) developing and implementing interventions targeting known adherence determinants; (4) using patient-centred approaches to evaluating adherence barriers and facilitators; (5) measuring adherence, including refining and testing instruments; and (6) testing the association between adherence and PFMT outcome.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  consensus statement; exercise; pelvic floor muscle training; treatment adherence

Mesh:

Year:  2015        PMID: 25998603     DOI: 10.1002/nau.22796

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  21 in total

1.  Better together: multidisciplinary approach improves adherence to pelvic floor physical therapy.

Authors:  Heidi W Brown; Hayley C Barnes; Amy Lim; Dobie L Giles; Sarah E McAchran
Journal:  Int Urogynecol J       Date:  2019-08-28       Impact factor: 2.894

2.  Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT.

Authors:  Suzanne Hagen; Carol Bugge; Sarah G Dean; Andrew Elders; Jean Hay-Smith; Mary Kilonzo; Doreen McClurg; Mohamed Abdel-Fattah; Wael Agur; Federico Andreis; Joanne Booth; Maria Dimitrova; Nicola Gillespie; Cathryn Glazener; Aileen Grant; Karen L Guerrero; Lorna Henderson; Marija Kovandzic; Alison McDonald; John Norrie; Nicole Sergenson; Susan Stratton; Anne Taylor; Louise R Williams
Journal:  Health Technol Assess       Date:  2020-12       Impact factor: 4.014

3.  Learning about pelvic floor muscle exercises before and during pregnancy: a cross-sectional study.

Authors:  Deirdre Daly; Cinny Cusack; Cecily Begley
Journal:  Int Urogynecol J       Date:  2019-01-05       Impact factor: 2.894

Review 4.  Physical, Complementary, and Alternative Medicine in the Treatment of Pelvic Floor Disorders.

Authors:  Alex Arnouk; Elise De; Alexandra Rehfuss; Carin Cappadocia; Samantha Dickson; Fei Lian
Journal:  Curr Urol Rep       Date:  2017-06       Impact factor: 3.092

5.  Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction.

Authors:  Valter Silva; Antonio Jose Grande; Maria S Peccin
Journal:  Cochrane Database Syst Rev       Date:  2019-04-06

6.  Adherence to pelvic floor muscle training with or without vaginal spheres in women with urinary incontinence: a secondary analysis from a randomized trial.

Authors:  Oriol Porta Roda; Miguel A Díaz López; Jesús Vara Paniagua; Marta Simó González; Paloma Díaz Bellido; Juan J Espinós Gómez
Journal:  Int Urogynecol J       Date:  2016-01-15       Impact factor: 2.894

7.  Treatment of stress urinary incontinence with a mobile app: factors associated with success.

Authors:  Emma Nyström; Ina Asklund; Malin Sjöström; Hans Stenlund; Eva Samuelsson
Journal:  Int Urogynecol J       Date:  2017-12-08       Impact factor: 2.894

8.  Effectiveness and cost-effectiveness randomised controlled trial of basic versus biofeedback-mediated intensive pelvic floor muscle training for female stress or mixed urinary incontinence: protocol for the OPAL (optimising pelvic floor exercises to achieve long-term benefits) trial mixed methods longitudinal qualitative case study and process evaluation.

Authors:  Aileen Grant; Sarah Dean; Jean Hay-Smith; Suzanne Hagen; Doreen McClurg; Anne Taylor; Marija Kovandzic; Carol Bugge
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

9.  Innovative treatment modalities for urinary incontinence: a European survey identifying experience and attitude of healthcare providers.

Authors:  Arnoud W Kastelein; Maarten F A Dicker; Brent C Opmeer; Sonia S Angles; Kaisa E Raatikainen; Joan F Alonso; Diana Tăut; Olavi Airaksinen; Linda D Cardozo; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2017-04-21       Impact factor: 2.894

10.  Smartphone-based reminder system to promote pelvic floor muscle training for the management of postnatal urinary incontinence: historical control study with propensity score-matched analysis.

Authors:  Kaori Kinouchi; Kazutomo Ohashi
Journal:  PeerJ       Date:  2018-02-09       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.